X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-18 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $0.01 | -386,350 | 11,747,937 | -3% | -$4,250 | ||||||
| M | 2022-05-18 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | P - Purchase | $2.17 | +1,042,996 | 12,134,287 | +9% | +$2,263,991 | |||||
2022-03-11 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | P - Purchase | $3.00 | +1,000,000 | 11,091,291 | +10% | +$3,000,000 | ||||||
| M | 2022-03-08 | HGEN | Kilcoyne Adrian | Chief Medical Officer | P - Purchase | $2.63 | +12,000 | 12,000 | New | +$31,610 | |||||
2022-03-02 | HGEN | Durrant Cameron | CEO | P - Purchase | $2.34 | +40,000 | 70,000 | +133% | +$93,600 | ||||||
2022-03-02 | HGEN | Jordan Edward P. | Chief Commercial Officer | P - Purchase | $2.32 | +12,500 | 12,500 | New | +$29,000 | ||||||
| M | 2021-08-11 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.10 | -167,198 | 10,120,685 | -2% | -$2,859,709 | |||||
| M | 2021-07-28 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.04 | -39,086 | 10,258,489 | 0% | -$665,866 | |||||
| M | 2021-07-21 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.08 | -316,353 | 10,297,575 | -3% | -$5,403,074 | |||||
2021-07-14 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.06 | -15,177 | 10,613,928 | 0% | -$258,847 | ||||||
| M | 2021-07-08 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.34 | -344,046 | 10,629,105 | -3% | -$5,966,878 | |||||
| M | 2021-06-30 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.19 | -463,096 | 10,973,151 | -4% | -$7,959,379 | |||||
| M | 2021-06-23 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $17.92 | -1,272,655 | 11,436,247 | -10% | -$22,801,514 | |||||
| M | 2021-06-16 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $18.86 | -742,389 | 12,708,902 | -6% | -$14,000,186 | |||||
2021-06-14 | HGEN | Durrant Cameron | CEO | S - Sale | $20.64 | -81,441 | 30,000 | -73% | -$1,680,934 | ||||||
| D | 2021-06-08 | HGEN | Jordan Edward P. | Chief Commercial Officer | S - Sale+OE | $20.08 | -14,700 | 0 | -100% | -$295,176 | |||||
2021-06-07 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $19.08 | -80,636 | 13,451,291 | -1% | -$1,538,793 | ||||||
| M | 2021-06-02 | HGEN | Chappell Dale | Chief Scientific Officer, 10% | S - Sale | $18.52 | -394,364 | 13,531,927 | -3% | -$7,304,993 | |||||
| A | 2021-03-09 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $17.24 | -83,568 | 5,632,469 | -1% | -$1,440,495 | |||||
| M | 2021-03-09 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $16.51 | -235,238 | 5,342,887 | -4% | -$3,884,756 | |||||
| M | 2021-02-25 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $19.02 | -46,505 | 5,616,037 | -1% | -$884,432 | |||||
| M | 2021-02-22 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $22.29 | -103,220 | 5,662,542 | -2% | -$2,301,023 | |||||
| M | 2021-02-17 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $22.25 | -89,408 | 5,765,762 | -2% | -$1,989,619 | |||||
| M | 2021-02-11 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $19.72 | -16,973 | 5,855,170 | 0% | -$334,776 | |||||
| M | 2021-02-08 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $21.61 | -54,273 | 5,872,143 | -1% | -$1,172,582 | |||||
| M | 2021-02-02 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $20.96 | -73,584 | 5,926,416 | -1% | -$1,542,363 | |||||
| M | 2021-01-22 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $19.87 | -95,032 | 6,000,000 | -2% | -$1,888,332 | |||||
| M | 2021-01-19 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $20.29 | -8,500 | 6,165,032 | 0% | -$172,423 | |||||
| M | 2021-01-14 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $18.94 | -105,000 | 6,173,532 | -2% | -$1,989,020 | |||||
| M | 2021-01-11 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $18.67 | -25,000 | 6,278,532 | 0% | -$466,650 | |||||
2020-12-28 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $22.20 | -500 | 6,303,532 | 0% | -$11,101 | ||||||
| A | 2020-12-22 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $20.02 | -50,000 | 6,357,433 | -1% | -$1,000,985 | |||||
| M | 2020-12-23 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $21.24 | -53,401 | 6,304,032 | -1% | -$1,134,104 | |||||
| E | 2020-12-22 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $1.00 | -50,000 | 6,357,433 | -1% | -$50,000 | |||||
| DM | 2020-12-18 | HGEN | Nomis Bay Ltd. | 10% | S - Sale+OE | $16.82 | -87,700 | 6,407,433 | -1% | -$1,474,766 | |||||
2020-08-10 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $5.04 | -17,100 | 32,662,170 | 0% | -$86,099 | ||||||
2020-07-28 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $5.66 | -10,000 | 32,679,270 | 0% | -$56,550 | ||||||
| M | 2020-07-17 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $5.00 | -300,000 | 32,689,270 | -1% | -$1,500,190 | |||||
2020-06-30 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $4.91 | -3,000 | 32,989,270 | 0% | -$14,739 | ||||||
| M | 2020-06-15 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $5.63 | -65,000 | 32,992,270 | 0% | -$365,799 | |||||
| M | 2020-03-20 | HGEN | Nomis Bay Ltd. | 10% | S - Sale | $2.62 | -516,260 | 33,057,270 | -2% | -$1,353,281 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |